Digital health and back-to-work specialist Reframe appoints CEO

Digital health provider and back-to-work specialist Reframe has appointed former McKesson and Amazon director Catherine McDermott (pictured) as CEO.

McDermott’s appointment comes as the business looks to diversify from its core offering of personalised cancer support into multiple healthcare areas. Reframe partners with health insurance providers and finance businesses to provide their policyholders and employees with a “hyperpersonalised” approach to help them regain control and recover faster from unexpected and life-changing health events.

McDermott has over 16 years of experience in a leadership role across the healthcare and technology sectors. This includes spells at Circle Health and Amazon, where she spent four years in operations. She has also held senior roles at pharmaceuticals company McKesson and cancer data platform Repositive.

She said that Reframe has achieved “remarkable” growth over the last few years, building an “impressive” client roster of household names and healthcare providers.

She said: “Leading Reframe will allow me to fully indulge my passion for making tech work better for healthcare as we issue in a new era of hyperpersonalised, connected health and wellbeing services that will benefit companies and individuals alike.”

Reframe chairman Mike Kennedy said that the organisation’s primary focus is to build on our “experience and success in cancer care and support and serve as many people as possible, giving them the skills and confidence to self-manage their wellbeing no matter what life throws at them”.

He added: “Catherine is an inspirational leader with a wealth of experience and deep knowledge in transforming technology businesses – of all sizes – into world class market leaders that deliver results. Catherine’s creativity and strategic thinking will be a key driver in our growth efforts and strengthening our position in the market.”

A spokesperson for Reframe added that the strategy is underpinned by “significant” investment in developing advanced technologies, artificial intelligence and machine learning to deliver greatly enhanced and personalised healthcare experiences via Alix, Reframe’s digital health platform.

Exit mobile version